Commercial And Military Flight Simulation - Global Strategic Business Report
- Language: English
- 774 Pages
- Published: October 2012
- Region: World
Acacia Pharma Ltd. – Product Pipeline Review – Q4 2010
Summary
Global Market Direct’s pharmaceuticals report, “Acacia Pharma Ltd.- Product Pipeline Review - Q4 2010” provides data on the company’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.
This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company’s corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together by Global Markets Direct’s team.
Scope
- Acacia Pharma Ltd.- brief company overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Acacia Pharma Ltd.human therapeutic division.
- overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities,
READ MORE >
List of Tables
List of Figures
Acacia Pharma Ltd. Snapshot
Acacia Pharma Ltd. Overview
Key Information
Key Facts
Acacia Pharma Ltd. – Research and Development Overview
Key Therapeutic Areas
Acacia Pharma Ltd. – Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products – Monotherapy
Acacia Pharma Ltd. – Pipeline Products Glance
Acacia Pharma Ltd. Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Acacia Pharma Ltd.–Early Stage Pipeline Products
Pre-Clinical Products/Combination Treatment Modalities
Acacia Pharma Ltd. – Drug Profiles
APD209
Product Description
Mechanism of Action
R&D Progress
APD421
Product Description
Mechanism of Action
R&D Progress
APD515
Product Description
Mechanism of Action
R&D Progress
Acacia Pharma Ltd. – Pipeline Analysis
Acacia Pharma Ltd. – Pipeline Products by Therapeutic Class
Acacia Pharma Ltd. Pipeline Products By Target
Acacia Pharma Ltd. – Pipeline Products by Route of Administration
Acacia Pharma Ltd. – Recent Pipeline Updates
Acacia Pharma Ltd. - Discontinued Pipeline Products
Discontinued Pipeline Product Profiles
APD405
Acacia Pharma Ltd. – Locations And Subsidiaries
Head Office
Recent Developments
Sep 06, 2010: Acacia Pharma To Progress Two Projects For Nausea & Vomiting And Xerostomia Into Clinical Development
Sep 06, 2010: Acacia Pharma To Progress Two Projects For Nausea & Vomiting And Xerostomia Into Clinical Development
Dec 14, 2009: Acacia Pharma Completes Phase II Study With APD405 In Post-Operative Nausea & Vomiting (PONV)
Jun 08, 2009: Acacia Pharma Initiates Phase II Study With APD405 In Post-Operative Nausea & Vomiting (PONV)
Mar 31, 2009: Acacia Pharma Initiates Phase IIa Study With APD209 In Cancer Cachexia Patients
Jan 06, 2009: Acacia Pharma Completes Clinical Trial With APD 405 For Nausea & Vomiting
Sep 22, 2008: Acacia Pharma Starts First Clinical Trial With APD 405 For Nausea & Vomiting
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
| Format | Properties | |
|---|---|---|
| Electronic (PDF) | The report will be emailed to you. The report is sent in PDF format. | This is a single user license, allowing one specific user access to the product. |
| Site License | The report will be emailed to you. The report is sent in PDF format. | This is a site license, allowing all users within a given geographical location of your organisation access to the product. |
| Enterprisewide | The report will be emailed to you. The report is sent in PDF format. | This is an enterprise license, allowing all employees within your organisation access to the product. |